BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Irani V, Guy AJ, Andrew D, Beeson JG, Ramsland PA, Richards JS. Molecular properties of human IgG subclasses and their implications for designing therapeutic monoclonal antibodies against infectious diseases. Molecular Immunology 2015;67:171-82. [DOI: 10.1016/j.molimm.2015.03.255] [Cited by in Crossref: 179] [Cited by in F6Publishing: 161] [Article Influence: 25.6] [Reference Citation Analysis]
Number Citing Articles
1 Yang D, Kroe-Barrett R, Singh S, Roberts CJ, Laue TM. IgG cooperativity - Is there allostery? Implications for antibody functions and therapeutic antibody development. MAbs 2017;9:1231-52. [PMID: 28812955 DOI: 10.1080/19420862.2017.1367074] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 7.4] [Reference Citation Analysis]
2 Weaver R, Reiling L, Feng G, Drew DR, Mueller I, Siba PM, Tsuboi T, Richards JS, Fowkes FJI, Beeson JG. The association between naturally acquired IgG subclass specific antibodies to the PfRH5 invasion complex and protection from Plasmodium falciparum malaria. Sci Rep 2016;6:33094. [PMID: 27604417 DOI: 10.1038/srep33094] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 5.8] [Reference Citation Analysis]
3 Kurtovic L, Agius PA, Feng G, Drew DR, Ubillos I, Sacarlal J, Aponte JJ, Fowkes FJI, Dobaño C, Beeson JG. Induction and decay of functional complement-fixing antibodies by the RTS,S malaria vaccine in children, and a negative impact of malaria exposure. BMC Med 2019;17:45. [PMID: 30798787 DOI: 10.1186/s12916-019-1277-x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 10.7] [Reference Citation Analysis]
4 Mugyenyi CK, Elliott SR, Yap XZ, Feng G, Boeuf P, Fegan G, Osier FFH, Fowkes FJI, Avril M, Williams TN, Marsh K, Beeson JG. Declining Malaria Transmission Differentially Impacts the Maintenance of Humoral Immunity to Plasmodium falciparum in Children. J Infect Dis 2017;216:887-98. [PMID: 28973483 DOI: 10.1093/infdis/jix370] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
5 Donald LJ, Spearman M, Mishra N, Komatsu E, Butler M, Perreault H. Mass spectrometric analysis of core fucosylation and sequence variation in a human-camelid monoclonal antibody. Mol Omics 2020;16:221-30. [PMID: 32163054 DOI: 10.1039/c9mo00168a] [Reference Citation Analysis]
6 Wilkins MD, Turner BL, Rivera KR, Menegatti S, Daniele M. Quantum dot enabled lateral flow immunoassay for detection of cardiac biomarker NT-proBNP. Sensing and Bio-Sensing Research 2018;21:46-53. [DOI: 10.1016/j.sbsr.2018.10.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
7 Rademaker M, Agnew K, Andrews M, Armour K, Baker C, Foley P, Frew J, Gebauer K, Gupta M, Kennedy D, Marshman G, Sullivan J. Psoriasis in those planning a family, pregnant or breast-feeding. The Australasian Psoriasis Collaboration. Australas J Dermatol 2018;59:86-100. [PMID: 28543445 DOI: 10.1111/ajd.12641] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 6.2] [Reference Citation Analysis]
8 Sécher T, Guilleminault L, Reckamp K, Amanam I, Plantier L, Heuzé-Vourc'h N. Therapeutic antibodies: A new era in the treatment of respiratory diseases? Pharmacol Ther 2018;189:149-72. [PMID: 29730443 DOI: 10.1016/j.pharmthera.2018.05.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
9 Elias S, Kol I, Kahlon S, Amore R, Zeibak M, Mevorach D, Elchalal U, Zelig O, Mandelboim O. Anti-RhD antibody therapy modulates human natural killer cell function. Haematologica 2021;106:1846-56. [PMID: 32467141 DOI: 10.3324/haematol.2019.238097] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 McWilliams EM, Mele JM, Cheney C, Timmerman EA, Fiazuddin F, Strattan EJ, Mo X, Byrd JC, Muthusamy N, Awan FT. Therapeutic CD94/NKG2A blockade improves natural killer cell dysfunction in chronic lymphocytic leukemia. Oncoimmunology 2016;5:e1226720. [PMID: 27853650 DOI: 10.1080/2162402X.2016.1226720] [Cited by in Crossref: 65] [Cited by in F6Publishing: 51] [Article Influence: 10.8] [Reference Citation Analysis]
11 Jefferis R. Recombinant Proteins and Monoclonal Antibodies. In: Rapp E, Reichl U, editors. Advances in Glycobiotechnology. Cham: Springer International Publishing; 2021. pp. 281-318. [DOI: 10.1007/10_2017_32] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Ramsland PA, Hutchinson AT, Carter PJ. Therapeutic antibodies: Discovery, design and deployment. Mol Immunol 2015;67:1-3. [PMID: 25990602 DOI: 10.1016/j.molimm.2015.05.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
13 Akiba H, Satoh R, Nagata S, Tsumoto K. Effect of allotypic variation of human IgG1 on the thermal stability of disulfide-linked knobs-into-holes mutants of the Fc for stable bispecific antibody design. Antib Ther 2019;2:65-9. [PMID: 33928224 DOI: 10.1093/abt/tbz008] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 Lawrence MG, Steinke JW, Borish L. Cytokine-targeting biologics for allergic diseases. Ann Allergy Asthma Immunol 2018;120:376-81. [PMID: 29410215 DOI: 10.1016/j.anai.2018.01.009] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
15 Huang J, Qi Y, Zeng X, Huang W, Chen D. Simultaneous quantification of plasma immunoglobulin subclasses for assessment of maternal and fetal immune response during pregnancy. Journal of Chromatography A 2022. [DOI: 10.1016/j.chroma.2022.463096] [Reference Citation Analysis]
16 Bernth Jensen JM, Laursen NS, Jensen RK, Andersen GR, Jensenius JC, Sørensen UBS, Thiel S. Complement activation by human IgG antibodies to galactose-α-1,3-galactose. Immunology 2020;161:66-79. [PMID: 32583419 DOI: 10.1111/imm.13229] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
17 Jounai N, Yoshioka M, Tozuka M, Inoue K, Oka T, Miyaji K, Ishida K, Kawai N, Ikematsu H, Kawakami C, Shimizu H, Mori M, Ishii KJ, Takeshita F. Age-Specific Profiles of Antibody Responses against Respiratory Syncytial Virus Infection. EBioMedicine 2017;16:124-35. [PMID: 28111238 DOI: 10.1016/j.ebiom.2017.01.014] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
18 Lazaridis K, Dalianoudis I, Baltatzidi V, Tzartos SJ. Specific removal of autoantibodies by extracorporeal immunoadsorption ameliorates experimental autoimmune myasthenia gravis. Journal of Neuroimmunology 2017;312:24-30. [DOI: 10.1016/j.jneuroim.2017.09.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
19 Kurtovic L, Beeson JG. Complement Factors in COVID-19 Therapeutics and Vaccines. Trends Immunol 2021;42:94-103. [PMID: 33402318 DOI: 10.1016/j.it.2020.12.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
20 Pawlowski JW, Bajardi-taccioli A, Houde D, Feschenko M, Carlage T, Kaltashov IA. Influence of glycan modification on IgG1 biochemical and biophysical properties. Journal of Pharmaceutical and Biomedical Analysis 2018;151:133-44. [DOI: 10.1016/j.jpba.2017.12.061] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
21 Belinchón I, Velasco M, Ara-Martín M, Armesto Alonso S, Baniandrés Rodríguez O, Ferrándiz Pulido L, García-Bustinduy M, Martínez-López JA, Martínez Sánchez N, Pérez Ferriols A, Pérez Pascual E, Rivera Díaz R, Ruiz-Villaverde R, Taberner Ferrer R, Vicente Villa A, Carrascosa JM. Management of Psoriasis During Preconception, Pregnancy, Postpartum, and Breastfeeding: A Consensus Statement. Actas Dermosifiliogr (Engl Ed) 2021;112:225-41. [PMID: 33065101 DOI: 10.1016/j.ad.2020.10.002] [Reference Citation Analysis]
22 López-jácome E, Franco-cendejas R, Quezada H, Morales-espinosa R, Castillo-juárez I, González-pedrajo B, Fernández-presas AM, Tovar-garcía A, Angarita-zapata V, Licona-limón P, Martínez-vázquez M, García-contreras R. The race between drug introduction and appearance of microbial resistance. Current balance and alternative approaches. Current Opinion in Pharmacology 2019;48:48-56. [DOI: 10.1016/j.coph.2019.04.016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
23 Kerr RA, Keire DA, Ye H. The impact of standard accelerated stability conditions on antibody higher order structure as assessed by mass spectrometry. MAbs 2019;11:930-41. [PMID: 30913973 DOI: 10.1080/19420862.2019.1599632] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
24 Chu TH, Patz EF Jr, Ackerman ME. Coming together at the hinges: Therapeutic prospects of IgG3. MAbs 2021;13:1882028. [PMID: 33602056 DOI: 10.1080/19420862.2021.1882028] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
25 Giamarellos-Bourboulis EJ, Opal SM. The role of genetics and antibodies in sepsis. Ann Transl Med 2016;4:328. [PMID: 27713886 DOI: 10.21037/atm.2016.08.63] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
26 Correia-Neves M, Sundling C, Cooper A, Källenius G. Lipoarabinomannan in Active and Passive Protection Against Tuberculosis. Front Immunol 2019;10:1968. [PMID: 31572351 DOI: 10.3389/fimmu.2019.01968] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
27 Klaus T, Deshmukh S. pH-responsive antibodies for therapeutic applications. J Biomed Sci 2021;28:11. [PMID: 33482842 DOI: 10.1186/s12929-021-00709-7] [Reference Citation Analysis]
28 Klaus T, Bereta J. CH2 Domain of Mouse IgG3 Governs Antibody Oligomerization, Increases Functional Affinity to Multivalent Antigens and Enhances Hemagglutination. Front Immunol 2018;9:1096. [PMID: 29875771 DOI: 10.3389/fimmu.2018.01096] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
29 Liu-Shin LP, Fung A, Malhotra A, Ratnaswamy G. Evidence of disulfide bond scrambling during production of an antibody-drug conjugate. MAbs 2018;10:1190-9. [PMID: 30339473 DOI: 10.1080/19420862.2018.1521128] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
30 Cao J, Yi F, Tian Q, Dang G, Si W, Liu S, Yu S. Targeting the gram-negative bacteria peptidoglycan synthase MraY as a new approach for monoclonal antibody anti-bacterial activity. Hum Vaccin Immunother 2017;13:2086-91. [PMID: 28605292 DOI: 10.1080/21645515.2017.1337613] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
31 Marques AC, Costa PJ, Velho S, Amaral MH. Functionalizing nanoparticles with cancer-targeting antibodies: A comparison of strategies. J Control Release 2020;320:180-200. [PMID: 31978444 DOI: 10.1016/j.jconrel.2020.01.035] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 23.5] [Reference Citation Analysis]
32 Keeler SP, Fox JM. Requirement of Fc-Fc Gamma Receptor Interaction for Antibody-Based Protection against Emerging Virus Infections. Viruses 2021;13:1037. [PMID: 34072720 DOI: 10.3390/v13061037] [Reference Citation Analysis]
33 Hsiao PY, Kalin JH, Sun IH, Amin MN, Lo YC, Chiang MJ, Giddens J, Sysa-Shah P, Gabrielson K, Wang LX, Powell JD, Cole PA. An Fc-Small Molecule Conjugate for Targeted Inhibition of the Adenosine 2A Receptor. Chembiochem 2016;17:1951-60. [PMID: 27432157 DOI: 10.1002/cbic.201600337] [Reference Citation Analysis]
34 Nony E, Moingeon P. Proteomics in support of immunotherapy: contribution to model-based precision medicine. Expert Rev Proteomics 2021;:1-10. [PMID: 34937491 DOI: 10.1080/14789450.2021.2020653] [Reference Citation Analysis]
35 Cao Y, Su B, Guo X, Sun W, Deng Y, Bao L, Zhu Q, Zhang X, Zheng Y, Geng C, Chai X, He R, Li X, Lv Q, Zhu H, Deng W, Xu Y, Wang Y, Qiao L, Tan Y, Song L, Wang G, Du X, Gao N, Liu J, Xiao J, Su XD, Du Z, Feng Y, Qin C, Qin C, Jin R, Xie XS. Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells. Cell 2020;182:73-84.e16. [PMID: 32425270 DOI: 10.1016/j.cell.2020.05.025] [Cited by in Crossref: 594] [Cited by in F6Publishing: 528] [Article Influence: 297.0] [Reference Citation Analysis]
36 Maresch D, Altmann F. Isotype-specific glycosylation analysis of mouse IgG by LC-MS. Proteomics 2016;16:1321-30. [PMID: 26960168 DOI: 10.1002/pmic.201500367] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
37 Nguyen AW, Maynard JA. Engineering Antibody‐Based Therapeutics: Progress and Opportunities. In: Zhao H, Lee SY, Nielsen J, Stephanopoulos G, editors. Protein Engineering. Wiley; 2021. pp. 317-51. [DOI: 10.1002/9783527815128.ch13] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Beeson JG, Kurtovic L, Dobaño C, Opi DH, Chan J, Feng G, Good MF, Reiling L, Boyle MJ. Challenges and strategies for developing efficacious and long-lasting malaria vaccines. Sci Transl Med 2019;11:eaau1458. [DOI: 10.1126/scitranslmed.aau1458] [Cited by in Crossref: 54] [Cited by in F6Publishing: 41] [Article Influence: 18.0] [Reference Citation Analysis]
39 Martínez-ortega A, Herrera A, Salmerón-garcía A, Cabeza J, Perez-robles R, Navas N. Degradation and in-use stability study of five marketed therapeutic monoclonal antibodies by generic weak cation exchange liquid chromatographic method ((WCX)HPLC/DAD). Journal of Chromatography B 2022;1203:123295. [DOI: 10.1016/j.jchromb.2022.123295] [Reference Citation Analysis]
40 Zhou L, Zhang J, Digiammarino E, Kavishwar A, Yan B, Chumsae C, Ihnat PM, Powers D, Harlan J, Stine WB. PULSE SPR: A High Throughput Method to Evaluate the Domain Stability of Antibodies. Anal Chem 2018;90:12221-9. [DOI: 10.1021/acs.analchem.8b03452] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
41 Dudek S, Weißmüller S, Anzaghe M, Miller L, Sterr S, Hoffmann K, Hengel H, Waibler Z. Human Fcγ receptors compete for TGN1412 binding that determines the antibody's effector function. Eur J Immunol 2019;49:1117-26. [PMID: 31002172 DOI: 10.1002/eji.201847924] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
42 Firmino NS, Cederberg RA, Lee CM, Shi R, Wadsworth BJ, Franks SE, Thomas KN, Decotret LR, Bennewith KL. Germinal center hypoxia in tumor-draining lymph nodes negatively regulates tumor-induced humoral immune responses in mouse models of breast cancer. Oncoimmunology 2021;10:1959978. [PMID: 34377597 DOI: 10.1080/2162402X.2021.1959978] [Reference Citation Analysis]
43 Negm OH, MacKenzie B, Hamed MR, Ahmad OAJ, Shone CC, Humphreys DP, Ravi Acharya K, Loscher CE, Marszalowska I, Lynch M, Wilcox MH, Monaghan TM. Protective antibodies against Clostridium difficile are present in intravenous immunoglobulin and are retained in humans following its administration. Clin Exp Immunol 2017;188:437-43. [PMID: 28213939 DOI: 10.1111/cei.12946] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
44 Baldwin WM 3rd, Valujskikh A, Fairchild RL. The neonatal Fc receptor: Key to homeostasic control of IgG and IgG-related biopharmaceuticals. Am J Transplant 2019;19:1881-7. [PMID: 30903736 DOI: 10.1111/ajt.15366] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
45 Smith AM, Huber VC. The Unexpected Impact of Vaccines on Secondary Bacterial Infections Following Influenza. Viral Immunol 2018;31:159-73. [PMID: 29148920 DOI: 10.1089/vim.2017.0138] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
46 Chowdhury R, Allan MF, Maranas CD. OptMAVEn-2.0: De novo Design of Variable Antibody Regions against Targeted Antigen Epitopes. Antibodies (Basel) 2018;7:E23. [PMID: 31544875 DOI: 10.3390/antib7030023] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
47 Mazzarella L, Guida A, Curigliano G. Cetuximab for treating non-small cell lung cancer. Expert Opin Biol Ther 2018;18:483-93. [PMID: 29534625 DOI: 10.1080/14712598.2018.1452906] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
48 Iacob SA, Iacob DG. Ibalizumab Targeting CD4 Receptors, An Emerging Molecule in HIV Therapy. Front Microbiol 2017;8:2323. [PMID: 29230203 DOI: 10.3389/fmicb.2017.02323] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
49 Saito S, Namisaki H, Hiraishi K, Takahashi N, Iida S. A stable engineered human IgG3 antibody with decreased aggregation during antibody expression and low pH stress. Protein Sci 2019;28:900-9. [PMID: 30834577 DOI: 10.1002/pro.3598] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
50 Tanner JE, Hu J, Alfieri C. Construction and Characterization of a Humanized Anti-Epstein-Barr Virus gp350 Antibody with Neutralizing Activity in Cell Culture. Cancers (Basel) 2018;10:E112. [PMID: 29642526 DOI: 10.3390/cancers10040112] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
51 Reiling L, Boyle MJ, White MT, Wilson DW, Feng G, Weaver R, Opi DH, Persson KEM, Richards JS, Siba PM, Fowkes FJI, Takashima E, Tsuboi T, Mueller I, Beeson JG. Targets of complement-fixing antibodies in protective immunity against malaria in children. Nat Commun 2019;10:610. [PMID: 30723225 DOI: 10.1038/s41467-019-08528-z] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 11.7] [Reference Citation Analysis]
52 Yüce M, Sert F, Torabfam M, Parlar A, Gürel B, Çakır N, Dağlıkoca DE, Khan MA, Çapan Y. Fractionated charge variants of biosimilars: A review of separation methods, structural and functional analysis. Anal Chim Acta 2021;1152:238189. [PMID: 33648647 DOI: 10.1016/j.aca.2020.12.064] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
53 Foss S, Jonsson A, Bottermann M, Watkinson R, Lode HE, McAdam MB, Michaelsen TE, Sandlie I, James LC, Andersen JT. Potent TRIM21 and complement-dependent intracellular antiviral immunity requires the IgG3 hinge. Sci Immunol 2022;7:eabj1640. [PMID: 35486676 DOI: 10.1126/sciimmunol.abj1640] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Gao R, Sheng Z, Sreenivasan CC, Wang D, Li F. Influenza A Virus Antibodies with Antibody-Dependent Cellular Cytotoxicity Function. Viruses 2020;12:E276. [PMID: 32121563 DOI: 10.3390/v12030276] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
55 Dean AQ, Luo S, Twomey JD, Zhang B. Targeting cancer with antibody-drug conjugates: Promises and challenges. MAbs 2021;13:1951427. [PMID: 34291723 DOI: 10.1080/19420862.2021.1951427] [Reference Citation Analysis]
56 Alonso S, Vidal M, Ruiz-Olalla G, González R, Manaca MN, Jairoce C, Vázquez-Santiago M, Balcells R, Vala A, Rupérez M, Cisteró P, Fuente-Soro L, Cova M, Angov E, Nhacolo A, Sevene E, Aponte JJ, Macete E, Aguilar R, Mayor A, Menéndez C, Dobaño C, Moncunill G. Reduced Placental Transfer of Antibodies Against a Wide Range of Microbial and Vaccine Antigens in HIV-Infected Women in Mozambique. Front Immunol 2021;12:614246. [PMID: 33746958 DOI: 10.3389/fimmu.2021.614246] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Yaseen MM, Yaseen MM, Alqudah MA. Broadly neutralizing antibodies: An approach to control HIV-1 infection. Int Rev Immunol 2017;36:31-40. [PMID: 27739924 DOI: 10.1080/08830185.2016.1225301] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
58 Biswas M, Rogers GL, Sherman A, Byrne BJ, Markusic DM, Jiang H, Herzog RW. Combination therapy for inhibitor reversal in haemophilia A using monoclonal anti-CD20 and rapamycin. Thromb Haemost 2017;117:33-43. [PMID: 27683758 DOI: 10.1160/TH16-05-0404] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
59 Bhiman JN, Lynch RM. Broadly Neutralizing Antibodies as Treatment: Effects on Virus and Immune System. Curr HIV/AIDS Rep 2017;14:54-62. [PMID: 28349376 DOI: 10.1007/s11904-017-0352-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
60 Lakhanpal A, Brahn E. A perspective on modern advances for COVID-19 (SARS-CoV-2) therapeutics. Eur J Rheumatol 2020;7:S102-6. [PMID: 32449669 DOI: 10.5152/eurjrheum.2020.2065] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
61 Galson JD, Trück J, Kelly DF, van der Most R. Investigating the effect of AS03 adjuvant on the plasma cell repertoire following pH1N1 influenza vaccination. Sci Rep 2016;6:37229. [PMID: 27849037 DOI: 10.1038/srep37229] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 6.2] [Reference Citation Analysis]
62 Diem S, Fässler M, Bomze D, Ali OH, Berner F, Niederer R, Hillmann D, Mangana J, Levesque MP, Dummer R, Risch L, Recher M, Risch M, Flatz L. Immunoglobulin G and Subclasses as Potential Biomarkers in Metastatic Melanoma Patients Starting Checkpoint Inhibitor Treatment. J Immunother 2019;42:89-93. [PMID: 30768543 DOI: 10.1097/CJI.0000000000000255] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
63 van Kasteren SI, Neefjes J, Ovaa H. Creating molecules that modulate immune responses. Nat Rev Chem 2018;2:184-93. [DOI: 10.1038/s41570-018-0023-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
64 Feng G, Wines BD, Kurtovic L, Chan JA, Boeuf P, Mollard V, Cozijnsen A, Drew DR, Center RJ, Marshall DL, Chishimba S, McFadden GI, Dent AE, Chelimo K, Boyle MJ, Kazura JW, Hogarth PM, Beeson JG. Mechanisms and targets of Fcγ-receptor mediated immunity to malaria sporozoites. Nat Commun 2021;12:1742. [PMID: 33741975 DOI: 10.1038/s41467-021-21998-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
65 Barrientos G, Habazin S, Novokmet M, Almousa Y, Lauc G, Conrad ML. Changes in subclass-specific IgG Fc glycosylation associated with the postnatal maturation of the murine immune system. Sci Rep 2020;10:15243. [PMID: 32943699 DOI: 10.1038/s41598-020-71899-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
66 Opal SM. Non-antibiotic treatments for bacterial diseases in an era of progressive antibiotic resistance. Crit Care 2016;20:397. [PMID: 27978847 DOI: 10.1186/s13054-016-1549-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
67 Tandale JB, Badgujar SB, Tandale BU, Angre U, Daftary SB, Lala S, Gaur VP. An improved protocol for large scale production of high purity 'Fc' fragment of human immunoglobulin G (IgG-Fc). J Chromatogr B Analyt Technol Biomed Life Sci 2020;1159:122400. [PMID: 33126073 DOI: 10.1016/j.jchromb.2020.122400] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Vences-Catalán F, Kuo CC, Rajapaksa R, Duault C, Andor N, Czerwinski DK, Levy R, Levy S. CD81 is a novel immunotherapeutic target for B cell lymphoma. J Exp Med 2019;216:1497-508. [PMID: 31123084 DOI: 10.1084/jem.20190186] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
69 Lambour J, Naranjo-Gomez M, Piechaczyk M, Pelegrin M. Converting monoclonal antibody-based immunotherapies from passive to active: bringing immune complexes into play. Emerg Microbes Infect 2016;5:e92. [PMID: 27530750 DOI: 10.1038/emi.2016.97] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
70 Reese HR, Xiao X, Shanahan CC, Chu W, Van Den Driessche GA, Fourches D, Carbonell RG, Hall CK, Menegatti S. Novel peptide ligands for antibody purification provide superior clearance of host cell protein impurities. Journal of Chromatography A 2020;1625:461237. [DOI: 10.1016/j.chroma.2020.461237] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
71 Said SM, Cosio FG, Valeri AM, Leung N, Sethi S, Salameh H, Cornell LD, Fidler ME, Alexander MP, Fervenza FC, Drosou ME, Zhang D, D'Agati VD, Nasr SH. Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits is associated with high rate of early recurrence in the allograft. Kidney Int 2018;94:159-69. [PMID: 29716794 DOI: 10.1016/j.kint.2018.01.028] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
72 Fonseca MHG, Furtado GP, Bezerra MRL, Pontes LQ, Fernandes CFC. Boosting half-life and effector functions of therapeutic antibodies by Fc-engineering: An interaction-function review. International Journal of Biological Macromolecules 2018;119:306-11. [DOI: 10.1016/j.ijbiomac.2018.07.141] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
73 Richards JS, Ramsland PA. Human antibodies against DBP. Nat Microbiol 2019;4:1428-9. [DOI: 10.1038/s41564-019-0549-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
74 Hansen K, Lau AM, Giles K, Mcdonnell JM, Struwe WB, Sutton BJ, Politis A. A Mass‐Spectrometry‐Based Modelling Workflow for Accurate Prediction of IgG Antibody Conformations in the Gas Phase. Angew Chem 2018;130:17440-5. [DOI: 10.1002/ange.201812018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
75 Soliman C, Walduck AK, Yuriev E, Richards JS, Cywes-Bentley C, Pier GB, Ramsland PA. Structural basis for antibody targeting of the broadly expressed microbial polysaccharide poly-N-acetylglucosamine. J Biol Chem 2018;293:5079-89. [PMID: 29449370 DOI: 10.1074/jbc.RA117.001170] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 4.8] [Reference Citation Analysis]
76 Lofano G, Gorman MJ, Yousif AS, Yu WH, Fox JM, Dugast AS, Ackerman ME, Suscovich TJ, Weiner J, Barouch D, Streeck H, Little S, Smith D, Richman D, Lauffenburger D, Walker BD, Diamond MS, Alter G. Antigen-specific antibody Fc glycosylation enhances humoral immunity via the recruitment of complement. Sci Immunol 2018;3:eaat7796. [PMID: 30120121 DOI: 10.1126/sciimmunol.aat7796] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 11.0] [Reference Citation Analysis]
77 Hintersteiner B, Lingg N, Janzek E, Mutschlechner O, Loibner H, Jungbauer A. Microheterogeneity of therapeutic monoclonal antibodies is governed by changes in the surface charge of the protein. Biotechnol J 2016;11:1617-27. [PMID: 27753240 DOI: 10.1002/biot.201600504] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
78 Cavaco M, Castanho MARB, Neves V. Peptibodies: An elegant solution for a long-standing problem. Peptide Science 2018;110:e23095. [DOI: 10.1002/bip.23095] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
79 Hoxha E, Reinhard L, Stahl RAK. Membranous nephropathy: new pathogenic mechanisms and their clinical implications. Nat Rev Nephrol 2022. [PMID: 35484394 DOI: 10.1038/s41581-022-00564-1] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
80 Gurjar SA, Wheeler JX, Wadhwa M, Thorpe R, Kimber I, Derrick JP, Dearman RJ, Metcalfe C. The impact of thioredoxin reduction of allosteric disulfide bonds on the therapeutic potential of monoclonal antibodies. J Biol Chem 2019;294:19616-34. [PMID: 31727737 DOI: 10.1074/jbc.RA119.010637] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
81 Garcia NK, Deperalta G, Wecksler AT. Current Trends in Biotherapeutic Higher Order Structure Characterization by Irreversible Covalent Footprinting Mass Spectrometry. Protein Pept Lett 2019;26:35-43. [PMID: 30484396 DOI: 10.2174/0929866526666181128141953] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
82 Beccari MV, Mogle BT, Sidman EF, Mastro KA, Asiago-Reddy E, Kufel WD. Ibalizumab, a Novel Monoclonal Antibody for the Management of Multidrug-Resistant HIV-1 Infection. Antimicrob Agents Chemother 2019;63:e00110-19. [PMID: 30885900 DOI: 10.1128/AAC.00110-19] [Cited by in Crossref: 28] [Cited by in F6Publishing: 10] [Article Influence: 9.3] [Reference Citation Analysis]
83 Afridi SQ, Moeini H, Kalali B, Wettengel JM, Quitt O, Semper R, Gerhard M, Protzer U, Hoffmann D. Quantitation of norovirus-specific IgG before and after infection in immunocompromised patients. Braz J Microbiol 2020;51:183-7. [PMID: 31656022 DOI: 10.1007/s42770-019-00176-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
84 Dorokhov YL, Sheshukova EV, Kosobokova EN, Shindyapina AV, Kosorukov VS, Komarova TV. Functional role of carbohydrate residues in human immunoglobulin G and therapeutic monoclonal antibodies. Biochemistry Moscow 2016;81:835-57. [DOI: 10.1134/s0006297916080058] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
85 Li APY, Cohen CA, Leung NHL, Fang VJ, Gangappa S, Sambhara S, Levine MZ, Iuliano AD, Perera RAPM, Ip DKM, Peiris JSM, Thompson MG, Cowling BJ, Valkenburg SA. Immunogenicity of standard, high-dose, MF59-adjuvanted, and recombinant-HA seasonal influenza vaccination in older adults. NPJ Vaccines 2021;6:25. [PMID: 33594050 DOI: 10.1038/s41541-021-00289-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
86 Kurokawa K, Takahashi K, Lee BL. The staphylococcal surface-glycopolymer wall teichoic acid (WTA) is crucial for complement activation and immunological defense against Staphylococcus aureus infection. Immunobiology 2016;221:1091-101. [PMID: 27424796 DOI: 10.1016/j.imbio.2016.06.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
87 Nawab DH. Vaccinal antibodies: Fc antibody engineering to improve the antiviral antibody response and induce vaccine-like effects. Hum Vaccin Immunother 2021;:1-14. [PMID: 34844516 DOI: 10.1080/21645515.2021.1985891] [Reference Citation Analysis]
88 Rosenbaum P, Artaud C, Bay S, Ganneau C, Campone M, Delaloge S, Gourmelon C, Loirat D, Medioni J, Pein F, Sablin M, Tredan O, Varga A, Leclerc C. The fully synthetic glycopeptide MAG-Tn3 therapeutic vaccine induces tumor-specific cytotoxic antibodies in breast cancer patients. Cancer Immunol Immunother 2020;69:703-16. [DOI: 10.1007/s00262-020-02503-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
89 Pujol-Navarro N, Al Qaraghuli MM, Kubiak-Ossowska K, Alsaadi MM, Horne GA, Soutar RL, Paspali E, Ferro VA, Williams MT, Mulheran PA. Multiple myeloma: therapeutic delivery of antibodies and aptamers. Ther Deliv 2021;12:705-22. [PMID: 34569269 DOI: 10.4155/tde-2021-0041] [Reference Citation Analysis]
90 Christiansen D, Earnest-Silveira L, Grubor-Bauk B, Wijesundara DK, Boo I, Ramsland PA, Vincan E, Drummer HE, Gowans EJ, Torresi J. Pre-clinical evaluation of a quadrivalent HCV VLP vaccine in pigs following microneedle delivery. Sci Rep 2019;9:9251. [PMID: 31239471 DOI: 10.1038/s41598-019-45461-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
91 Chang TT, Tsai HW, Ho CH. Fucosyl-Agalactosyl IgG₁ Induces Cholangiocarcinoma Metastasis and Early Recurrence by Activating Tumor-Associated Macrophage. Cancers (Basel) 2018;10:E460. [PMID: 30469416 DOI: 10.3390/cancers10110460] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
92 Kadam K, Peerzada N, Karbhal R, Sawant S, Valadi J, Kulkarni-kale U. Antibody Class(es) Predictor for Epitopes (AbCPE): A Multi-Label Classification Algorithm. Front Bioinform 2021;1:709951. [DOI: 10.3389/fbinf.2021.709951] [Reference Citation Analysis]
93 Lu X, Machiesky LA, De Mel N, Du Q, Xu W, Washabaugh M, Jiang XR, Wang J. Characterization of IgG1 Fc Deamidation at Asparagine 325 and Its Impact on Antibody-dependent Cell-mediated Cytotoxicity and FcγRIIIa Binding. Sci Rep 2020;10:383. [PMID: 31941950 DOI: 10.1038/s41598-019-57184-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
94 Das S, Chowdhury R, Ghosh S, Das S. A recombinant protein of Salmonella Typhi induces humoral and cell-mediated immune responses including memory responses. Vaccine 2017;35:4523-31. [PMID: 28739115 DOI: 10.1016/j.vaccine.2017.07.035] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
95 Groff D, Carlos NA, Chen R, Hanson JA, Liang S, Armstrong S, Li X, Zhou S, Steiner A, Hallam TJ, Yin G. Development of an E. coli strain for cell-free ADC manufacturing. Biotechnol Bioeng 2022;119:162-75. [PMID: 34655229 DOI: 10.1002/bit.27961] [Reference Citation Analysis]
96 Farouq MAH, Kubiak-Ossowska K, Al Qaraghuli MM, Ferro VA, Mulheran PA. Functionalisation of Inorganic Material Surfaces with Staphylococcus Protein A: A Molecular Dynamics Study. Int J Mol Sci 2022;23:4832. [PMID: 35563221 DOI: 10.3390/ijms23094832] [Reference Citation Analysis]
97 de Vor L, Rooijakkers SHM, van Strijp JAG. Staphylococci evade the innate immune response by disarming neutrophils and forming biofilms. FEBS Lett 2020;594:2556-69. [PMID: 32144756 DOI: 10.1002/1873-3468.13767] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
98 Shah HB, Smith K, Wren JD, Webb CF, Ballard JD, Bourn RL, James JA, Lang ML. Insights From Analysis of Human Antigen-Specific Memory B Cell Repertoires. Front Immunol 2018;9:3064. [PMID: 30697210 DOI: 10.3389/fimmu.2018.03064] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
99 Zwolak A, Leettola CN, Tam SH, Goulet DR, Derebe MG, Pardinas JR, Zheng S, Decker R, Emmell E, Chiu ML. Rapid Purification of Human Bispecific Antibodies via Selective Modulation of Protein A Binding. Sci Rep 2017;7:15521. [PMID: 29138497 DOI: 10.1038/s41598-017-15748-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
100 Geyer CE, Mes L, Newling M, den Dunnen J, Hoepel W. Physiological and Pathological Inflammation Induced by Antibodies and Pentraxins. Cells 2021;10:1175. [PMID: 34065953 DOI: 10.3390/cells10051175] [Reference Citation Analysis]
101 Lankipalli S, Ramagopal UA. A structural perspective on the design of decoy immune modulators. Pharmacol Res 2021;170:105735. [PMID: 34146695 DOI: 10.1016/j.phrs.2021.105735] [Reference Citation Analysis]
102 Ssewanyana I, Rek J, Rodriguez I, Wu L, Arinaitwe E, Nankabirwa JI, Beeson JG, Mayanja-Kizza H, Rosenthal PJ, Dorsey G, Kamya MR, Drakeley C, Greenhouse B, Tetteh KKA. Impact of a Rapid Decline in Malaria Transmission on Antimalarial IgG Subclasses and Avidity. Front Immunol 2020;11:576663. [PMID: 33584643 DOI: 10.3389/fimmu.2020.576663] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
103 Sobarzo A, Stonier SW, Radinsky O, Gelkop S, Kuehne AI, Edri A, Herbert AS, Fedida-Metula S, Lutwama JJ, Yavelsky V, Davis C, Porgador A, Dye JM, Lobel L. Multiple viral proteins and immune response pathways act to generate robust long-term immunity in Sudan virus survivors. EBioMedicine 2019;46:215-26. [PMID: 31326432 DOI: 10.1016/j.ebiom.2019.07.021] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
104 Peschiera I, Giuliani M, Giusti F, Melero R, Paccagnini E, Donnarumma D, Pansegrau W, Carazo JM, Sorzano COS, Scarselli M, Masignani V, Liljeroos LJ, Ferlenghi I. Structural basis for cooperativity of human monoclonal antibodies to meningococcal factor H-binding protein. Commun Biol 2019;2:241. [PMID: 31263785 DOI: 10.1038/s42003-019-0493-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
105 Opi DH, Kurtovic L, Chan JA, Horton JL, Feng G, Beeson JG. Multi-functional antibody profiling for malaria vaccine development and evaluation. Expert Rev Vaccines 2021;20:1257-72. [PMID: 34530671 DOI: 10.1080/14760584.2021.1981864] [Reference Citation Analysis]
106 Jucaud V, Nguyen A, Tran B, Hopfield J, Pham T. Validation and cross-reactivity pattern assessment of monoclonal antibodies used for the screening of donor-specific IgG antibody subclasses in transplant recipients. J Immunol Methods 2020;486:112847. [PMID: 32888965 DOI: 10.1016/j.jim.2020.112847] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
107 Arlotta KJ, Owen SC. Antibody and antibody derivatives as cancer therapeutics. WIREs Nanomed Nanobiotechnol 2019;11. [DOI: 10.1002/wnan.1556] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
108 Choi YH, Lee HW, Purdy MA. Natural antibody IgG levels are associated with HBeAg-positivity and seroconversion in chronic hepatitis B patients treated with entecavir. Sci Rep 2022;12:4382. [PMID: 35288624 DOI: 10.1038/s41598-022-08457-w] [Reference Citation Analysis]
109 Soliman C, Pier GB, Ramsland PA. Antibody recognition of bacterial surfaces and extracellular polysaccharides. Curr Opin Struct Biol 2020;62:48-55. [PMID: 31874385 DOI: 10.1016/j.sbi.2019.12.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
110 Grigoletto A, Tedeschini T, Canato E, Pasut G. The evolution of polymer conjugation and drug targeting for the delivery of proteins and bioactive molecules. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2021;13:e1689. [PMID: 33314717 DOI: 10.1002/wnan.1689] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
111 Märcher A, Palmfeldt J, Nisavic M, Gothelf KV. A Reagent for Amine‐Directed Conjugation to IgG1 Antibodies. Angew Chem 2021;133:6613-8. [DOI: 10.1002/ange.202013911] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
112 Stelter S, Paul MJ, Teh AY, Grandits M, Altmann F, Vanier J, Bardor M, Castilho A, Allen RL, Ma JK. Engineering the interactions between a plant-produced HIV antibody and human Fc receptors. Plant Biotechnol J 2020;18:402-14. [PMID: 31301102 DOI: 10.1111/pbi.13207] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
113 Crowley AR, Ackerman ME. Mind the Gap: How Interspecies Variability in IgG and Its Receptors May Complicate Comparisons of Human and Non-human Primate Effector Function. Front Immunol 2019;10:697. [PMID: 31024542 DOI: 10.3389/fimmu.2019.00697] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 8.7] [Reference Citation Analysis]
114 Castro-Dopico T, Clatworthy MR. IgG and Fcγ Receptors in Intestinal Immunity and Inflammation. Front Immunol 2019;10:805. [PMID: 31031776 DOI: 10.3389/fimmu.2019.00805] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
115 Prabhakar AK, Potroz MG, Park S, Miyako E, Cho N. Spatially Controlled Molecular Encapsulation in Natural Pine Pollen Microcapsules. Part Part Syst Charact 2018;35:1800151. [DOI: 10.1002/ppsc.201800151] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
116 Motley MP, Diago-Navarro E, Banerjee K, Inzerillo S, Fries BC. The Role of IgG Subclass in Antibody-Mediated Protection against Carbapenem-Resistant Klebsiella pneumoniae. mBio 2020;11:e02059-20. [PMID: 32900809 DOI: 10.1128/mBio.02059-20] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
117 Reese HR, Shanahan CC, Lembo J, Tsonev L, Hirsh A, Menegatti S. Chromatographic assay to probe the binding energy and mechanisms of homologous proteins to surface-bound ligands. Journal of Chromatography B 2020;1136:121927. [DOI: 10.1016/j.jchromb.2019.121927] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
118 Hansen K, Lau AM, Giles K, McDonnell JM, Struwe WB, Sutton BJ, Politis A. A Mass-Spectrometry-Based Modelling Workflow for Accurate Prediction of IgG Antibody Conformations in the Gas Phase. Angew Chem Int Ed Engl 2018;57:17194-9. [PMID: 30408305 DOI: 10.1002/anie.201812018] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
119 Verma M, Suryanarayana N, Tuteja U, Thavachelvam K, Rao MK, Bhargava R, Shukla S. Anthrax lethal toxin (LeTx) neutralization by PA domain specific antisera. Toxicon 2017;139:58-65. [PMID: 28919458 DOI: 10.1016/j.toxicon.2017.09.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
120 Wines BD, Billings H, Mclean MR, Kent SJ, Hogarth PM. Antibody Functional Assays as Measures of Fc Receptor-Mediated Immunity to HIV - New Technologies and their Impact on the HIV Vaccine Field. Curr HIV Res 2017;15:202-15. [PMID: 28322167 DOI: 10.2174/1570162X15666170320112247] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
121 More AS, Toth RT 4th, Okbazghi SZ, Middaugh CR, Joshi SB, Tolbert TJ, Volkin DB, Weis DD. Impact of Glycosylation on the Local Backbone Flexibility of Well-Defined IgG1-Fc Glycoforms Using Hydrogen Exchange-Mass Spectrometry. J Pharm Sci 2018;107:2315-24. [PMID: 29751008 DOI: 10.1016/j.xphs.2018.04.026] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
122 Anderson R, Rapoport BL. Immune Dysregulation in Cancer Patients Undergoing Immune Checkpoint Inhibitor Treatment and Potential Predictive Strategies for Future Clinical Practice. Front Oncol 2018;8:80. [PMID: 29623257 DOI: 10.3389/fonc.2018.00080] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
123 Mugo RM, Mwai K, Mwacharo J, Shee FM, Musyoki JN, Wambua J, Otieno E, Bejon P, Ndungu FM. Seven-year kinetics of RTS, S/AS01-induced anti-CSP antibodies in young Kenyan children. Malar J 2021;20:452. [PMID: 34856981 DOI: 10.1186/s12936-021-03961-2] [Reference Citation Analysis]
124 Kurtovic L, Boyle MJ, Opi DH, Kennedy AT, Tham WH, Reiling L, Chan JA, Beeson JG. Complement in malaria immunity and vaccines. Immunol Rev 2020;293:38-56. [PMID: 31556468 DOI: 10.1111/imr.12802] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
125 Paris J, Morgan TE, Marzullo BP, Wootton CA, Barrow MP, O'Hara J, O'Connor PB. Two-Dimensional Mass Spectrometry Analysis of IgG1 Antibodies. J Am Soc Mass Spectrom 2021;32:1716-24. [PMID: 34152763 DOI: 10.1021/jasms.1c00096] [Reference Citation Analysis]
126 Horowitz RI, Freeman PR. Precision Medicine: The Role of the MSIDS Model in Defining, Diagnosing, and Treating Chronic Lyme Disease/Post Treatment Lyme Disease Syndrome and Other Chronic Illness: Part 2. Healthcare (Basel) 2018;6:E129. [PMID: 30400667 DOI: 10.3390/healthcare6040129] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
127 Ketterer B, Moore-Kelly C, Thomas ORT, Franzreb M. Integrated system for temperature-controlled fast protein liquid chromatography. III. Continuous downstream processing of monoclonal antibodies. J Chromatogr A 2020;1609:460429. [PMID: 31431354 DOI: 10.1016/j.chroma.2019.460429] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
128 Hinz SC, Elter A, Rammo O, Schwämmle A, Ali A, Zielonka S, Herget T, Kolmar H. A Generic Procedure for the Isolation of pH- and Magnesium-Responsive Chicken scFvs for Downstream Purification of Human Antibodies. Front Bioeng Biotechnol 2020;8:688. [PMID: 32656201 DOI: 10.3389/fbioe.2020.00688] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
129 Orino K. Binding of Immunoglobulin G to Protoporphyrin IX and Its Derivatives: Evidence the Fab Domain Recognizes the Protoporphyrin Ring. Antibodies (Basel) 2019;8:E6. [PMID: 31544812 DOI: 10.3390/antib8010006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
130 Zhai Y, Moosavi R, Chen M. Immune Checkpoints, a Novel Class of Therapeutic Targets for Autoimmune Diseases. Front Immunol 2021;12:645699. [PMID: 33968036 DOI: 10.3389/fimmu.2021.645699] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
131 Mayor A, Chesnay A, Desoubeaux G, Ternant D, Heuzé-Vourc'h N, Sécher T. Therapeutic Antibodies for the Treatment of Respiratory Tract Infections-Current Overview and Perspectives. Vaccines (Basel) 2021;9:151. [PMID: 33668613 DOI: 10.3390/vaccines9020151] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
132 Zhang D, Chen B, Wang Y, Xia P, He C, Liu Y, Zhang R, Zhang M, Li Z. Disease-specific IgG Fc N-glycosylation as personalized biomarkers to differentiate gastric cancer from benign gastric diseases. Sci Rep 2016;6:25957. [PMID: 27173519 DOI: 10.1038/srep25957] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
133 Prodjinotho UF, von Horn C, Debrah AY, Batsa Debrah L, Albers A, Layland LE, Hoerauf A, Adjobimey T. Pathological manifestations in lymphatic filariasis correlate with lack of inhibitory properties of IgG4 antibodies on IgE-activated granulocytes. PLoS Negl Trop Dis 2017;11:e0005777. [PMID: 28742098 DOI: 10.1371/journal.pntd.0005777] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
134 Feng G, Boyle MJ, Cross N, Chan JA, Reiling L, Osier F, Stanisic DI, Mueller I, Anders RF, McCarthy JS, Richards JS, Beeson JG. Human Immunization With a Polymorphic Malaria Vaccine Candidate Induced Antibodies to Conserved Epitopes That Promote Functional Antibodies to Multiple Parasite Strains. J Infect Dis 2018;218:35-43. [PMID: 29584918 DOI: 10.1093/infdis/jiy170] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
135 Al Qaraghuli MM, Kubiak-Ossowska K, Mulheran PA. Thinking outside the Laboratory: Analyses of Antibody Structure and Dynamics within Different Solvent Environments in Molecular Dynamics (MD) Simulations. Antibodies (Basel) 2018;7:E21. [PMID: 31544873 DOI: 10.3390/antib7030021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
136 Nettey L, Ballard R, Liechti T, Mason RD. OMIP 074: Phenotypic analysis of IgG and IgA subclasses on human B cells. Cytometry A 2021;99:880-3. [PMID: 33939254 DOI: 10.1002/cyto.a.24341] [Reference Citation Analysis]
137 Kanje S, von Witting E, Chiang SC, Bryceson YT, Hober S. Site-Specific Photolabeling of the IgG Fab Fragment Using a Small Protein G Derived Domain. Bioconjug Chem 2016;27:2095-102. [PMID: 27491005 DOI: 10.1021/acs.bioconjchem.6b00346] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
138 Chen XL, Zheng H, Li WG, Zhong YH, Chen XP, Lu JX. Direct Blood Culturing of Candida spp. on Solid Medium by a Rapid Enrichment Method with Magnetic Beads Coated with Recombinant Human Mannan-Binding Lectin. J Clin Microbiol 2020;58:e00057-20. [PMID: 32051260 DOI: 10.1128/JCM.00057-20] [Reference Citation Analysis]
139 Chang RYK, Nang SC, Chan HK, Li J. Novel antimicrobial agents for combating antibiotic-resistant bacteria. Adv Drug Deliv Rev 2022;187:114378. [PMID: 35671882 DOI: 10.1016/j.addr.2022.114378] [Reference Citation Analysis]
140 Shores LS, Kelly SH, Hainline KM, Suwanpradid J, MacLeod AS, Collier JH. Multifactorial Design of a Supramolecular Peptide Anti-IL-17 Vaccine Toward the Treatment of Psoriasis. Front Immunol 2020;11:1855. [PMID: 32973764 DOI: 10.3389/fimmu.2020.01855] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
141 Billings H, Wines BD, Dyer WB, Center RJ, Trist HM, Kent SJ, Hogarth PM. Boosting of Markers of Fcγ Receptor Function in Anti-HIV Antibodies During Structured Treatment Interruption. AIDS Res Hum Retroviruses 2019;35:842-52. [PMID: 31288562 DOI: 10.1089/AID.2019.0047] [Reference Citation Analysis]
142 Fan L, Xia J, Shen J, Fang Q, Xia H, Zheng M, Han JH, Han ET, Wang B, Xu Y. An Erythrocyte Membrane-Associated Antigen, PvTRAg-26 of Plasmodium vivax: A Study of Its Antigenicity and Immunogenicity. Front Public Health 2020;8:148. [PMID: 32411650 DOI: 10.3389/fpubh.2020.00148] [Reference Citation Analysis]
143 Matera MG, Calzetta L, Rogliani P, Cazzola M. Monoclonal antibodies for severe asthma: Pharmacokinetic profiles. Respir Med 2019;153:3-13. [PMID: 31136930 DOI: 10.1016/j.rmed.2019.05.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
144 Rathe JA, Hemann EA, Eggenberger J, Li Z, Knoll ML, Stokes C, Hsiang TY, Netland J, Takehara KK, Pepper M, Gale M Jr. SARS-CoV-2 Serologic Assays in Control and Unknown Populations Demonstrate the Necessity of Virus Neutralization Testing. J Infect Dis 2021;223:1120-31. [PMID: 33367830 DOI: 10.1093/infdis/jiaa797] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
145 Stalin Raj V, Okba NMA, Gutierrez-Alvarez J, Drabek D, van Dieren B, Widagdo W, Lamers MM, Widjaja I, Fernandez-Delgado R, Sola I, Bensaid A, Koopmans MP, Segalés J, Osterhaus ADME, Bosch BJ, Enjuanes L, Haagmans BL. Chimeric camel/human heavy-chain antibodies protect against MERS-CoV infection. Sci Adv 2018;4:eaas9667. [PMID: 30101189 DOI: 10.1126/sciadv.aas9667] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 11.8] [Reference Citation Analysis]
146 Märcher A, Palmfeldt J, Nisavic M, Gothelf KV. A Reagent for Amine‐Directed Conjugation to IgG1 Antibodies. Angew Chem Int Ed 2021;60:6539-44. [DOI: 10.1002/anie.202013911] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
147 Zhao J, Jiang L, Deng L, Xu W, Cao Y, Chen C, Yang Y, Wu H, Huang Y, Zhu Z, Huang H. Important roles of CD32 in promoting suppression of IL-4 induced immune responses by a novel anti-IL-4Rα therapeutic antibody. MAbs 2019;11:837-47. [PMID: 30950681 DOI: 10.1080/19420862.2019.1601985] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
148 Ha JH, Kim JE, Kim YS. Immunoglobulin Fc Heterodimer Platform Technology: From Design to Applications in Therapeutic Antibodies and Proteins. Front Immunol 2016;7:394. [PMID: 27766096 DOI: 10.3389/fimmu.2016.00394] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 6.5] [Reference Citation Analysis]
149 Sarween N, Drayson MT, Hodson J, Knox EM, Plant T, Day CJ, Lipkin GW. Humoral immunity in late-onset Pre-eclampsia and linkage with angiogenic and inflammatory markers. Am J Reprod Immunol 2018;80:e13041. [DOI: 10.1111/aji.13041] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
150 Živković I, Petrović R, Arsenović-Ranin N, Petrušić V, Minić R, Bufan B, Popović O, Leposavić G. Sex bias in mouse humoral immune response to influenza vaccine depends on the vaccine type. Biologicals 2018;52:18-24. [PMID: 29426673 DOI: 10.1016/j.biologicals.2018.01.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
151 Diavatopoulos DA, Edwards KM. What Is Wrong with Pertussis Vaccine Immunity? Why Immunological Memory to Pertussis Is Failing. Cold Spring Harb Perspect Biol 2017;9:a029553. [PMID: 28289059 DOI: 10.1101/cshperspect.a029553] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
152 Wahl A, van den Akker E, Klaric L, Štambuk J, Benedetti E, Plomp R, Razdorov G, Trbojević-Akmačić I, Deelen J, van Heemst D, Slagboom PE, Vučković F, Grallert H, Krumsiek J, Strauch K, Peters A, Meitinger T, Hayward C, Wuhrer M, Beekman M, Lauc G, Gieger C. Genome-Wide Association Study on Immunoglobulin G Glycosylation Patterns. Front Immunol 2018;9:277. [PMID: 29535710 DOI: 10.3389/fimmu.2018.00277] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
153 Cavaco M, Gaspar D, Arb Castanho M, Neves V. Antibodies for the Treatment of Brain Metastases, a Dream or a Reality? Pharmaceutics 2020;12:E62. [PMID: 31940974 DOI: 10.3390/pharmaceutics12010062] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
154 Job ER, Schotsaert M, Ibañez LI, Smet A, Ysenbaert T, Roose K, Dai M, de Haan CAM, Kleanthous H, Vogel TU, Saelens X. Antibodies Directed toward Neuraminidase N1 Control Disease in a Mouse Model of Influenza. J Virol 2018;92:e01584-17. [PMID: 29167342 DOI: 10.1128/JVI.01584-17] [Cited by in Crossref: 6] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
155 Chu TH, Crowley AR, Backes I, Chang C, Tay M, Broge T, Tuyishime M, Ferrari G, Seaman MS, Richardson SI, Tomaras GD, Alter G, Leib D, Ackerman ME. Hinge length contributes to the phagocytic activity of HIV-specific IgG1 and IgG3 antibodies. PLoS Pathog 2020;16:e1008083. [PMID: 32092122 DOI: 10.1371/journal.ppat.1008083] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
156 Bratanis E, Molina H, Naegeli A, Collin M, Lood R. BspK, a Serine Protease from the Predatory Bacterium Bdellovibrio bacteriovorus with Utility for Analysis of Therapeutic Antibodies. Appl Environ Microbiol 2017;83:e03037-16. [PMID: 27940543 DOI: 10.1128/AEM.03037-16] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
157 Li H, Wang XX, Wang B, Fu L, Liu G, Lu Y, Cao M, Huang H, Javid B. Latently and uninfected healthcare workers exposed to TB make protective antibodies against Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 2017;114:5023-8. [PMID: 28438994 DOI: 10.1073/pnas.1611776114] [Cited by in Crossref: 67] [Cited by in F6Publishing: 56] [Article Influence: 13.4] [Reference Citation Analysis]
158 Amorim FM, Nobre ML, Nascimento LS, Miranda AM, Monteiro GRG, Freire-Neto FP, Queiroz MDCP, Queiroz JW, Duthie MS, Costa MR, Reed SG, Johnson WD Jr, Dupnik KM, Jeronimo SMB. Differential immunoglobulin and complement levels in leprosy prior to development of reversal reaction and erythema nodosum leprosum. PLoS Negl Trop Dis 2019;13:e0007089. [PMID: 30689631 DOI: 10.1371/journal.pntd.0007089] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
159 Sanchez L, Vidal M, Jairoce C, Aguilar R, Ubillos I, Cuamba I, Nhabomba AJ, Williams NA, Díez-Padrisa N, Cavanagh D, Angov E, Coppel RL, Gaur D, Beeson JG, Dutta S, Aide P, Campo JJ, Moncunill G, Dobaño C. Antibody responses to the RTS,S/AS01E vaccine and Plasmodium falciparum antigens after a booster dose within the phase 3 trial in Mozambique. NPJ Vaccines 2020;5:46. [PMID: 32550014 DOI: 10.1038/s41541-020-0192-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
160 Grujic O, Stevens J, Chou RY, Weiszmann JV, Sekirov L, Thomson C, Badh A, Grauer S, Chan B, Graham K, Manchulenko K, Dillon TM, Li Y, Foltz IN. Impact of antibody subclass and disulfide isoform differences on the biological activity of CD200R and βklotho agonist antibodies. Biochem Biophys Res Commun 2017;486:985-91. [PMID: 28363871 DOI: 10.1016/j.bbrc.2017.03.145] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
161 Blanco MA, Hatch HW, Curtis JE, Shen VK. Evaluating the Effects of Hinge Flexibility on the Solution Structure of Antibodies at Concentrated Conditions. J Pharm Sci 2019;108:1663-74. [PMID: 30593783 DOI: 10.1016/j.xphs.2018.12.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
162 Remesh SG, Armstrong AA, Mahan AD, Luo J, Hammel M. Conformational Plasticity of the Immunoglobulin Fc Domain in Solution. Structure 2018;26:1007-1014.e2. [PMID: 29731233 DOI: 10.1016/j.str.2018.03.017] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
163 Gondim DR, Cecilia JA, Rodrigues TNB, Vilarrasa-García E, Rodríguez-Castellón E, Azevedo DCS, Silva IJ Jr. Protein Adsorption onto Modified Porous Silica by Single and Binary Human Serum Protein Solutions. Int J Mol Sci 2021;22:9164. [PMID: 34502072 DOI: 10.3390/ijms22179164] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
164 Epp A, Sullivan KC, Herr AB, Strait RT. Immunoglobulin Glycosylation Effects in Allergy and Immunity. Curr Allergy Asthma Rep 2016;16:79. [PMID: 27796794 DOI: 10.1007/s11882-016-0658-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
165 Suurs FV, Lub-de Hooge MN, de Vries EGE, de Groot DJA. A review of bispecific antibodies and antibody constructs in oncology and clinical challenges. Pharmacol Ther 2019;201:103-19. [PMID: 31028837 DOI: 10.1016/j.pharmthera.2019.04.006] [Cited by in Crossref: 77] [Cited by in F6Publishing: 68] [Article Influence: 25.7] [Reference Citation Analysis]
166 Agostini S, Mancuso R, Hernis A, Costa AS, Nemni R, Clerici M. HSV-1-Specific IgG Subclasses Distribution and Serum Neutralizing Activity in Alzheimer's Disease and in Mild Cognitive Impairment. J Alzheimers Dis 2018;63:131-8. [PMID: 29578484 DOI: 10.3233/JAD-170966] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 3.7] [Reference Citation Analysis]
167 Zarrineh M, Mashhadi IS, Farhadpour M, Ghassempour A. Mechanism of antibodies purification by protein A. Anal Biochem 2020;609:113909. [PMID: 32827466 DOI: 10.1016/j.ab.2020.113909] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
168 Nupur N, Rathore AS. Usability of NISTmAb reference material for biosimilar analytical development. Anal Bioanal Chem 2019;411:2867-83. [DOI: 10.1007/s00216-019-01735-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
169 Hoepel W, Allahverdiyeva S, Harbiye H, de Taeye SW, van der Ham AJ, de Boer L, Zaat SAJ, van Weeghel M, Baeten DLP, Houtkooper RH, Everts B, Vidarsson G, den Dunnen J. IgG Subclasses Shape Cytokine Responses by Human Myeloid Immune Cells through Differential Metabolic Reprogramming. J Immunol 2020;205:3400-7. [PMID: 33188071 DOI: 10.4049/jimmunol.2000263] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
170 Howie HL, Collins B, Wang X, Kapp L, Delaney M, Er LS, Lebedev JN, Zimring JC. Characterization and refinement of monoclonal anti-human globulins that lack reactivity with human IgG4. Transfusion 2020;60:1060-8. [PMID: 32369193 DOI: 10.1111/trf.15796] [Reference Citation Analysis]
171 Garzón-Ospina D, Buitrago SP. Igh locus structure and evolution in Platyrrhines: new insights from a genomic perspective. Immunogenetics 2020;72:165-79. [PMID: 31838542 DOI: 10.1007/s00251-019-01151-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
172 Lew MH, Noordin R, Monsur Alam Khan M, Tye GJ. Immune Stimulation of RAP domain binding protein (rTgRA15) from Toxoplasma gondii. Pathog Glob Health 2018;112:387-94. [PMID: 30332344 DOI: 10.1080/20477724.2018.1536854] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
173 Alonso S, Vidal M, Ruiz-Olalla G, González R, Jairoce C, Manaca MN, Vázquez-Santiago M, Balcells R, Vala A, Rupérez M, Cisteró P, Fuente-Soro L, Angov E, Coppel RL, Gamain B, Cavanagh D, Beeson JG, Nhacolo A, Sevene E, Aponte JJ, Macete E, Aguilar R, Mayor A, Menéndez C, Dobaño C, Moncunill G. HIV infection and placental malaria reduce maternal transfer of multiple antimalarial antibodies in Mozambican women. J Infect 2021;82:45-57. [PMID: 33636218 DOI: 10.1016/j.jinf.2021.02.024] [Reference Citation Analysis]
174 Freiberger SN, Zehnder M, Gafvelin G, Grönlund H, Kündig TM, Johansen P. IgG4 but no IgG1 antibody production after intralymphatic immunotherapy with recombinant MAT-Feld1 in human. Allergy 2016;71:1366-70. [PMID: 27253988 DOI: 10.1111/all.12946] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
175 König N, Paulus M, Julius K, Schulze J, Voetz M, Tolan M. Antibodies under pressure: A Small-Angle X-ray Scattering study of Immunoglobulin G under high hydrostatic pressure. Biophys Chem 2017;231:45-9. [PMID: 28622937 DOI: 10.1016/j.bpc.2017.05.016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
176 Zwarthoff SA, Widmer K, Kuipers A, Strasser J, Ruyken M, Aerts PC, de Haas CJC, Ugurlar D, den Boer MA, Vidarsson G, van Strijp JAG, Gros P, Parren PWHI, van Kessel KPM, Preiner J, Beurskens FJ, Schuurman J, Ricklin D, Rooijakkers SHM. C1q binding to surface-bound IgG is stabilized by C1r2s2 proteases. Proc Natl Acad Sci U S A 2021;118:e2102787118. [PMID: 34155115 DOI: 10.1073/pnas.2102787118] [Reference Citation Analysis]
177 Wu L, Mwesigwa J, Affara M, Bah M, Correa S, Hall T, Singh SK, Beeson JG, Tetteh KKA, Kleinschmidt I, D'Alessandro U, Drakeley C. Antibody responses to a suite of novel serological markers for malaria surveillance demonstrate strong correlation with clinical and parasitological infection across seasons and transmission settings in The Gambia. BMC Med 2020;18:304. [PMID: 32972398 DOI: 10.1186/s12916-020-01724-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
178 Dewulf J, Adhikari K, Vangestel C, Wyngaert TVD, Elvas F. Development of Antibody Immuno-PET/SPECT Radiopharmaceuticals for Imaging of Oncological Disorders-An Update. Cancers (Basel) 2020;12:E1868. [PMID: 32664521 DOI: 10.3390/cancers12071868] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]